ADAR and neoplasm: Two groups also showed that knockdown of ADAR1 reduced the sensitivity of several tumor cells to antitumor drugs by activating interferons (IFNs), meaning that ADAR1 is able to enhance the effects of certain tumor immune drugs (139, 140).